Healthy donors get drug to supercharge immune cells
NCT ID NCT06040918
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a drug called N-803 in 10 healthy volunteers to see if it could help collect and grow more natural killer cells from their blood. The main goal was to check safety and side effects. The study is already complete, but it does not test whether these cells can fight any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- N-803 (a drug given as a shot under the skin)
- What this could lead to
- If successful, this could help improve methods for collecting and growing natural killer cells for future therapies.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It only looks at safety and cell collection, not whether the cells can treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chan Soon-Shiong Institute for Medicine
El Segundo, California, 90245, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children